|
⚲
|
| Christopher Rowland | |
|---|---|
| Firm | |
| Address | c/o Highline Capital Management, LP One Rockefeller Plaza, 23rd Floor New York, NY 10020 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM ($M) |
|---|---|---|---|---|---|
| Highline Enhanced Qualified Ltd | 021-303422 | Director | 31.1 M | ||
| Medigus Ltd | 021-299735 | Executive Officer | 0.0 M of 0.0 M |
||
| Medigus Ltd | 021-244383 | Executive Officer | 3.0 M of 3.0 M |
||
| Neotract Inc | 021-154828 | Executive Officer | 26.0 M of 27.3 M |
||
| Highline Enhanced Ltd | 021-140691 | Director | 64.0 M | ||
| Highline Capital International Ltd | 021-93711 | Director | 1.1 B | ||
| Highline Capital Management LP | |||||
| Highline Capital Qualified Master LP | 021-278618 | Director | 17.8 M | 1.0 | |
| Highline Capital Qualified Master LP | 021-225797 | Director | 317.3 M | 220.6 | |